Self-monitoring of blood glucose (SMBG) is essential to diabetes management. SMBG helps individuals with diabetes, and their healthcare professionals maintain a specific level of glycemic control and prevent hypoglycemia. SMBG collects blood glucose level data at various times to help maintain a more consistent glucose level through more accurate regimens. SMBG can also help adjust therapy regimens in response to blood glucose values and assist individuals in improving their dietary intake, physical activities, and insulin doses to enhance glycemic management daily.
People living with diabetes worldwide
- In 2021, 11.6% of Americans have diabetes, which includes 2 million with type 1 diabetes and 304,000 children with the condition.
- In 2023, In Canada, over 11.9 million individuals are currently affected by either diabetes or prediabetes.
- In the UK, there are over 4.3 million individuals who are living with diabetes.
- In 2022, Diabetes cases in Italy have increased from 2.9 million in 2010 to 3.9 million recently.
- In February 2023, approximately 1.2 million people in the Netherlands are affected by diabetes.
- The prevalence of diabetes among Chinese adults in 2020 is 11.2%, which amounts to approximately 141 million people, according to the NCBI.
- A 2023 ICMR study found that 101 million Indians have diabetes, a 36% increase from the 2021 estimate of 74.2 million.
- As of 2021, 11 million adults in Japan have diabetes, 11.8% of the total adult population.
- Over 73 million people in MENA have diabetes and it's expected to reach 135.7 million by 2045.
- In South Africa, there are over 4 million people who are living with diabetes.
China SMBG Market
China has the world's largest population of people with diabetes, with an estimated 141 million adults living with the disease. More than half of the adults currently living with diabetes in China are undiagnosed. The government has launched a 2017-2025 plan to control non-communicable diseases, including diabetes, and increase regular monitoring and self-management. Innovative technologies like digital health apps can further support self-management while decreasing disease burden. In 2023, Sinocare Inc. set up offline after-sales service outlets to explore new ways of preventing and controlling chronic diseases in China.Self-Monitoring Blood Glucose Device Company Analysis
Abbott Laboratories, Medtronic, Dexcom, Inc., B. Braun Melsungen AG, DarioHealth Corp, Sanofi, Bionime Corporation, and Novo Nordisk are the major companies in the global self-monitoring blood glucose device market.Self-Monitoring Blood Glucose Device Industry News
Dexcom G7, the latest CGM system, became available in Canada in October 2023. It features a subcutaneous sensor that transmits data via Bluetooth to a mobile app or receiver every five minutes.- In June 2023, South Korea's Ministry of Food and Drug Safety has approved CareSens Air, the smallest and lightest continuous glucose monitoring (CGM) device developed by i-SENS, for use in the country. The device features a calibration mechanism and can be used continuously for 15 days.
- In March 2023- The U.S. FDA approved Abbott's FreeStyle Libre 2 and FreeStyle Libre 3 sensors for integration with automated insulin delivery systems.
- In Feb 2023- Apple significantly advanced non-invasive blood glucose monitoring for its Watch.
- In Feb 2023, Ascensia Diabetes Care Holdings AG, the inventor of the CONTOUR BGM system portfolio, globally partnered with SNAQ, a mobile application that presents nutritional understandings for people with diabetes.
- One Drop announced a study on their AI-powered blood glucose forecasting in July 2022.
Products - Market breakup in 3 viewpoints:
1. Test Strips2. Lancets
3. Blood Glucose Meters
Application - Market breakup in 3 viewpoints:
1. Type 1 Diabetes2. Type 2 Diabetes
3. Gestational Diabetes
End User - Market breakup in 4 viewpoints:
1. Hospital Pharmacies2. Retail Pharmacies
3. Online Sales
4. Diabetes Clinics & Centers
Countries - Market breakup in 25 viewpoints:
1. North America1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 New Zealand
3.9 Australia
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 United Arab Emirates
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
1. Abbott Laboratories2. Medtronic
3. Dexcom, Inc.
4. B. Braun Melsungen AG,
5. DarioHealth Corp,
6. Sanofi
7. Bionime Corporation
8. Novo Nordisk
Table of Contents
Companies Mentioned
- Abbott Laboratories
- Medtronic
- Dexcom, Inc.
- B. Braun Melsungen AG,
- DarioHealth Corp,
- Sanofi
- Bionime Corporation
- Novo Nordisk
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | June 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 11.68 Billion |
| Forecasted Market Value ( USD | $ 21.05 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
